Old Web
English
Sign In
Acemap
>
authorDetail
>
Thomas A. Lanz
Thomas A. Lanz
Chemistry
Amyloid precursor protein secretase
Biochemistry
Cerebrospinal fluid
Pharmacology
3
Papers
332
Citations
0.01
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Studies of Aβ Pharmacodynamics in the Brain, Cerebrospinal Fluid, and Plasma in Young (Plaque-Free) Tg2576 Mice Using the γ-Secretase Inhibitor N2-[(2S)-2-(3,5-Difluorophenyl)-2-hydroxyethanoyl]-N1-[(7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-yl]-L-alaninamide (LY-411575)
2004
Journal of Pharmacology and Experimental Therapeutics
Thomas A. Lanz
John D. Hosley
Wade J. Adams
Kalpana M. Merchant
Show All
Source
Cite
Save
Citations (125)
Lack of Specific Amyloid-β(1-42) Suppression by Nonsteroidal Anti-Inflammatory Drugs in Young, Plaque-Free Tg2576 Mice and in Guinea Pig Neuronal Cultures
2004
Journal of Pharmacology and Experimental Therapeutics
Thomas A. Lanz
Gregory J. Fici
Kalpana M. Merchant
Show All
Source
Cite
Save
Citations (66)
The γ-Secretase Inhibitor N-[N-(3,5-Difluorophenacetyl)-l-alanyl]-S-phenylglycine t-butyl Ester Reduces Aβ Levels in Vivo in Plasma and Cerebrospinal Fluid in Young (Plaque-Free) and Aged (Plaque-Bearing) Tg2576 Mice
2003
Journal of Pharmacology and Experimental Therapeutics
Thomas A. Lanz
Carol S Himes
Giovanni Pallante
Lisa A. Adams
Shinji Yamazaki
Ben M Amore
Kalpana M. Merchant
Show All
Source
Cite
Save
Citations (141)
1